Furthermore, MSTN levels are increased in OHSS patients' follicular fluid and granulosa cells, leading to increased aromatase and E2 levels, both of which contribute to OHSS pathogenesis [104]. The gene discussed is CYP19A1; the disease is ovarian hyperstimulation syndrome.